$NVS: Novartis Q1 2019 Earnings Preview

Date: Tuesday, April 23rd, 2019

Stock(s) mentioned:

Source: Seeking Alpha (https://seekingalpha.com)

Summary: Novartis (NYSE:NVS) is scheduled to announce Q1 earnings results on Wednesday, April 24th, before market open. The consensus EPS Estimate is $1.14 …

Full article address: https://seekingalpha.com/news/3452939-novartis-q1-2019-earnings-preview

Related News:

$RHHBY $NVS $BIIB $IONS: Biogen’s New Study to Test Higher Dose of SMA Drug Spinraza

$CBPO $NVS: The Daily Biotech Pulse: China Biologics Receives Buyout Offer …

$NVS: Novartis SMA gene therapy shows sustained benefit in late-stage …

$NVS: Ionis Pharmaceuticals And IONIS-GHR-LRx In Acromegaly

$ABBV $JNJ $BMY $NVS: Novartis Announces New Data on Spondylitis Drug Cosentyx

$RHHBY $JNJ $MRK $NVS: J&J Files sBLA for Tremfya With FDA for Psoriatic Arthritis

$NVS: Novartis’ Cosentyx meets key endpoint in late-stage nr-axSpA study

$NVS $RHHBY $AZN $BIIB: Biogen Stops Late-Stage Studies on Alzheimer’s Candidate

$NVS $MRK $PFE $AZN $LLY: Breast Cancer Drugs May Inflame Lungs Per FDA Safety Alert

$TREX $ENPH $ALC $NVS $RAD $TGE: Trex, Enphase Energy, Alcon: ‘Mad Money’ Lightning Round

$NVS $REGN $ADVM $EDIT: Adverum Reports Data From Phase I Wet AMD Study, Stock Down

Latest News:

$NKE $KO: Kobe Bryant isn’t surprised by Nike’s support of former NFL player Kaepernick

$AMAT: Applied Materials (AMAT) Up 8.9% Since Last Earnings Report: Can It Continue?

$ARAY: Why Is Accuray (ARAY) Down 1% Since Last Earnings Report?

$CSIQ: Canadian Solar (CSIQ) Down 7.7% Since Last Earnings Report: Can It Rebound?

$DDS: Why Is Dillard’s (DDS) Up 18.9% Since Last Earnings Report?

$JCP: Why Is Penney (JCP) Up 66.6% Since Last Earnings Report?

$DE: Deere (DE) Up 15.1% Since Last Earnings Report: Can It Continue?

$AAPL: Rolling Covered Calls Up and Out

$SCVL: Will Shoe Carnival Continue to Surge Higher?

$DIS $SPX $AAPL: Disney Stock Could Be Held Back by Weakness in Its Film Division, Says Analyst

$STZ.B $CGC $SPX $DJIA: At Constellation Brands, the Beer Business ‘Remains Very Healthy’